{
    "Trade/Device Name(s)": [
        "ARCHITECT Galectin-3 Reagent Kit",
        "ARCHITECT Galectin-3 Calibrators",
        "ARCHITECT Galectin-3 Controls"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K140436",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093758"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OSX",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "November 12, 2014",
    "Summary Letter Received Date": "November 13, 2014",
    "Submission Date": "November 12, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1117",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system",
        "Calibrator",
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Galectin-3"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System",
        "ARCHITECT i 2000SR System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "CMIA"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Galectin-3 assay using chemiluminescent microparticle immunoassay for quantitative galectin-3 determination in serum and EDTA plasma",
    "Indications for Use Summary": "Quantitative determination of galectin-3 in human serum and EDTA plasma as an aid in assessing the prognosis of patients diagnosed with chronic heart failure, used with the ARCHITECT i System.",
    "fda_folder": "Clinical Chemistry"
}